Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sulfacetamide sodium is a synthetic sulfonamide antibiotic primarily used to treat bacterial infections of the skin and eyes, such as acne vulgaris, seborrheic dermatitis, blepharitis, and conjunctivitis. It works by competitively inhibiting the enzyme dihydropteroate synthase in bacteria, thereby blocking the synthesis of folic acid—a component essential for bacterial growth and replication. This results in bacteriostatic (growth-inhibiting) effects against susceptible Gram-positive and Gram-negative organisms, including Streptococci, Staphylococci, E. coli, and others. Sulfacetamide sodium is available in multiple formulations (e.g., solution, lotion, cream, ophthalmic drops) and is often combined with sulfur for dermatologic use to enhance efficacy in conditions like acne and rosacea.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sulfacetamide sodium.